Condition:   Rheumatoid Arthritis
Interventions:   Drug: tocilizumab [RoActemra/Actemra];   Drug: methotrexate;   Drug: DMARD
Sponsors:   Hoffmann-La Roche;   Hoffmann-La Roche
Not yet recruiting - verified September 2013